Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Non-cash Items (2023 - 2025)

Historic Non-cash Items for Beta Bionics (BBNX) over the last 3 years, with Q3 2025 value amounting to $3.5 million.

  • Beta Bionics' Non-cash Items changed N/A to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year change of. This contributed to the annual value of $2.9 million for FY2024, which is 43975.29% up from last year.
  • Beta Bionics' Non-cash Items amounted to $3.5 million in Q3 2025.
  • In the past 5 years, Beta Bionics' Non-cash Items ranged from a high of $46.2 million in Q1 2025 and a low of $535000.0 during Q4 2023
  • In the last 3 years, Beta Bionics' Non-cash Items had a median value of $3.5 million in 2025 and averaged $19.4 million.
  • Within the past 5 years, the most significant YoY rise in Beta Bionics' Non-cash Items was 43975.29% (2024), while the steepest drop was 43975.29% (2024).
  • Over the past 3 years, Beta Bionics' Non-cash Items (Quarter) stood at $535000.0 in 2023, then surged by 439.75% to $2.9 million in 2024, then increased by 22.47% to $3.5 million in 2025.
  • Its Non-cash Items stands at $3.5 million for Q3 2025, versus $43.8 million for Q2 2025 and $46.2 million for Q1 2025.